ALX Oncology (ALXO) PT Lowered to $25 at UBS
Tweet
Share
E-mailGet Alerts ALXO Hot Sheet
Price: $2.07 +4.02%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UBS analyst Colin Bristow lowered the price target on ALX Oncology (NASDAQ: ALXO) to $25.00 (from $27.00) while maintaining a Buy rating.
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Navios Maritime Partners (NMM) PT Raised to $100 at Jefferies
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
